Insmed | Driftsresultatet



Operating Profit Endring Dato
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Cytokinetics USD -139040000 1.76M 2024-12
DBV Technologies USD -30328000 3.51M 2024-09
Dynavax Technologies USD -1632000 11.71M 2024-12
Gilead Sciences USD 2.45B 1.56B 2024-12
Insmed USD -230414000 16.98M 2024-12
Novartis USD 3.4B 193M 2024-12
Regeneron Pharmaceuticals USD 990.2M 189.3M 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



Insmed Driftsresultatet - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.